Takumi Ochiai

Efficacy and safety of neoadjuvant chemotherapy with oxaliplatin, 5-fluorouracil, and levofolinate for T3 or T4 stage II/III rectal cancer: the FACT trial

Junichi Koike, Kimihiko Funahashi, Kazuhiko Yoshimatsu et al. · Cancer Chemotherapy and Pharmacology · 2017 · 50 citations

Medicine, Oncology, Surgery +14

Prognostic impact of orotate phosphoribosyl transferase among 5‐fluorouracil metabolic enzymes in resectable colorectal cancers treated by oral 5‐fluorouracil‐based adjuvant chemotherapy

Takumi Ochiai, Kazuhiko Nishimura, H. Noguchi et al. · International Journal of Cancer · 2006 · 28 citations · Full text

Medicine, Oncology, Pharmacology +16

Mechanism underlying the transient increase of serum iron during FOLFOX/FOLFIRI therapy

Takumi Ochiai, Kazuhiko Nishimura, Tomoo Watanabe et al. · Molecular and Clinical Oncology · 2014 · 16 citations · Full text

Medicine, Hematology, Oncology +15

Effect of gastrectomy on the pharmacokinetics of 5-fluorouracil and gimeracil after oral administration of S-1

Yuko Tsuruoka, Toshiki Kamano, Masayuki Kitajima et al. · Anti-Cancer Drugs · 2006 · 16 citations

Medicine, Pharmacokinetics, Pharmacology +15

Impact of 5-fluorouracil metabolizing enzymes on chemotherapy in patients with resectable colorectal cancer

Takumi Ochiai, Masahiko UMEKI, Hiroshi Miyake et al. · Oncology Reports · 2014 · 16 citations · Full text

Medicine, Oncology, Pharmacology +17